[一种能够准确导航目标可控药物释放的温度响应多模式运动微机器人的合成]
Xuhui Zhao1,2, Mengran Liu1, Xi Chen2,3
1Hubei Provincial Key Laboratory of Modern Manufacture Quality Engineering, Hubei University of Technology, Wuhan 430068, China.
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
|September 8, 2025
概括
研究人员开发了一种温度敏感的多式运动微机器人 (MMMR),用于向药物输送. 这种微机器人使用磁场和温度进行精确的导航和控制药物释放,用于生物医学应用.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 机器人技术 机器人技术 机器人技术
背景情况:
- 精确的药物输送仍然是医学上的一个挑战.
- 微机器人为有针对性的治疗干预提供了潜力.
研究的目的:
- 合成一个温度敏感的多式运动微机器人 (MMMR).
- 通过微流体滴滴技术实现有针对性的药物输送和受控释放.
主要方法:
- 使用微流体滴滴技术与凝和磁性微粒合成的MMMR.
- 微机器人使用旋转磁场进行线性和循环运动来导航.
- 激光加热触发了药物从凝基质中释放出来.
主要成果:
- MMMRs证明了沿着预定义的路径控制的线性和循环运动.
- 成功地实现了磁导向到目标位置的成功.
- 激光诱导的加热能够准确地局部释放药物.
结论:
- 开发的MMMR表现出多式联动运动,用于精确的导航.
- 目标区域内的药物释放的动态调节是可能的.
- MMMR显示出各种生物医学应用的巨大潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


